News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,807 Results
Type
Article (86642)
Company Profile (703)
Press Release (762460)
Multimedia
Podcasts (135)
Webinars (17)
Section
Business (232740)
Career Advice (4129)
Deals (39735)
Drug Delivery (129)
Drug Development (91029)
Employer Resources (198)
FDA (18140)
Job Trends (17348)
News (396613)
Policy (39778)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (98)
Alliances (56902)
ALS (110)
Alzheimer's disease (1528)
Antibody-drug conjugate (ADC) (177)
Approvals (18088)
Artificial intelligence (358)
Autoimmune disease (32)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (122)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (35)
Breast cancer (361)
Cancer (2775)
Cardiovascular disease (226)
Career advice (3536)
Career pathing (34)
CAR-T (194)
Cell therapy (536)
Cervical cancer (22)
Clinical research (73822)
Collaboration (990)
Company closure (3)
Compensation (606)
Complete response letters (30)
COVID-19 (2892)
CRISPR (58)
C-suite (298)
Cystic fibrosis (113)
Data (2695)
Decentralized trials (2)
Denatured (47)
Depression (60)
Diabetes (320)
Diagnostics (6950)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (115)
Earnings (97397)
Editorial (47)
Employer branding (25)
Employer resources (168)
Events (130961)
Executive appointments (856)
FDA (19684)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (897)
Gene editing (135)
Generative AI (36)
Gene therapy (401)
GLP-1 (880)
Government (5196)
Grass and pollen (6)
Guidances (179)
Healthcare (20905)
Huntington's disease (28)
IgA nephropathy (35)
Immunology and inflammation (164)
Immuno-oncology (4)
Indications (32)
Infectious disease (3061)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (110)
Interviews (813)
IPO (17868)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (50)
Layoffs (576)
Leadership (25)
Legal (10125)
Liver cancer (82)
Lung cancer (394)
Lymphoma (187)
Machine learning (9)
Management (65)
Manufacturing (395)
MASH (90)
Medical device (14672)
Medtech (14677)
Mergers & acquisitions (22501)
Metabolic disorders (855)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (127)
Neuropsychiatric disorders (37)
Neuroscience (2204)
NextGen: Class of 2025 (7685)
Non-profit (5087)
Now hiring (44)
Obesity (451)
Opinion (282)
Ovarian cancer (92)
Pain (108)
Pancreatic cancer (102)
Parkinson's disease (179)
Partnered (25)
Patents (277)
Patient recruitment (132)
Peanut (53)
People (65492)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22794)
Phase II (32057)
Phase III (24136)
Pipeline (1566)
Policy (200)
Postmarket research (3552)
Preclinical (10289)
Press Release (72)
Prostate cancer (131)
Psychedelics (39)
Radiopharmaceuticals (275)
Rare diseases (474)
Real estate (7396)
Recruiting (75)
Regulatory (26932)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (8)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (155)
Series B (105)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (78)
Tariffs (61)
The Weekly (86)
Vaccines (851)
Venture capitalists (48)
Weight loss (311)
Women's health (45)
Worklife (20)
Date
Today (202)
Last 7 days (828)
Last 30 days (3502)
Last 365 days (35179)
2025 (15346)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (66)
Alaska (7)
Arizona (276)
Arkansas (14)
Asia (50323)
Australia (8850)
California (7231)
Canada (2246)
China (638)
Colorado (308)
Connecticut (324)
Delaware (182)
Europe (115461)
Florida (1061)
Georgia (246)
Hawaii (1)
Idaho (65)
Illinois (694)
India (31)
Indiana (363)
Iowa (16)
Japan (204)
Kansas (115)
Kentucky (30)
Louisiana (16)
Maine (72)
Maryland (1042)
Massachusetts (5540)
Michigan (262)
Minnesota (453)
Mississippi (3)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (76)
New Hampshire (72)
New Jersey (2018)
New Mexico (31)
New York (2034)
North Carolina (1199)
North Dakota (10)
Northern California (3123)
Ohio (238)
Oklahoma (16)
Oregon (48)
Pennsylvania (1555)
Puerto Rico (17)
Rhode Island (38)
South America (1653)
South Carolina (31)
South Dakota (1)
Southern California (2662)
Tennessee (118)
Texas (1089)
United States (27406)
Utah (210)
Virginia (194)
Washington D.C. (77)
Washington State (649)
West Virginia (4)
Wisconsin (80)
There are 849,807 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
June 2, 2025
·
7 min read
Press Releases
Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
June 2, 2025
·
6 min read
Press Releases
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
June 2, 2025
·
4 min read
Press Releases
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
June 2, 2025
·
4 min read
Press Releases
Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions
June 2, 2025
·
13 min read
Press Releases
Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
June 2, 2025
·
1 min read
Press Releases
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
June 2, 2025
·
9 min read
Press Releases
XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson’s Diseases, Spinal Cord Injury and ALS
June 2, 2025
·
4 min read
Press Releases
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML
June 2, 2025
·
4 min read
Press Releases
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
June 2, 2025
·
5 min read
1 of 84,981
Next
